Clinical Trial Results:
Evaluation of the anti-anginal efficacy and safety of oral administration of ivabradine compared to placebo on top of a background therapy with atenolol in patients with stable angina pectoris.
A 4-month randomised double-blind parallel-group international multicentre study.
Summary
|
|
EudraCT number |
2004-001960-30 |
Trial protocol |
HU NO SE SK CZ GB IT ES DE |
Global completion date |
17 Oct 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v3(current) |
This version publication date |
15 Feb 2017
|
First version publication date |
31 Jul 2015
|
Other versions |
v1 (removed from public view) , v2 (removed from public view) |
Version creation reason |
|
Summary report(s) |
Synopsis dated 20 June 2008 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.